Workflow
CB1 inverse agonists
icon
搜索文档
Corbus Pharmaceuticals Holdings (NasdaqCM:CRBP) Update / Briefing Transcript
2025-12-11 22:02
Corbus Pharmaceuticals Holdings (NasdaqCM:CRBP) Update / Briefing December 11, 2025 08:00 AM ET Company ParticipantsDaniel Lee - Board-certified PsychiatristYuval Cohen - CEO and DirectorFelicia Berben - Biotech Equity Research AssociateSarah Barenbaum - Assistant Professor of Clinical MedicineBrian Abrahams - Managing Director and Co-Head of Biotechnology ResearchDominic Smethurst - Chief Medical OfficerConference Call ParticipantsGraig Suvannavejh - Biotech and Biopharma AnalystOperatorGood morning and we ...